CONMED urges holders to vote the GOLD proxy card CONMED announced that it will mail a letter to shareholders in connection with the company's September 10 Annual Meeting. CONMED's board unanimously recommends that shareholders vote for all CONMED's eight director nominees as well as the other proposals contained in the definitive proxy materials on the GOLD proxy card.
CONMED sees revenue growth accelerating in 2H15 CONMED has outlined certain changes in the structure of its commercial organization that management believes will return the company to sales growth in 2015. The company anticipates constant currency sales growth of 1% to 3% for the full year, which will be driven by new product launches and a reorganization of certain aspects of the commercial sales organization in early 2015. As a result, management expects revenue growth to accelerate in the second half of 2015 compared to the first half of 2015.